Moderna Faces Hurdle With Coronavirus Vaccine As Court Refuses To Invalidate Arbutus Patent – Yahoo Finance

Moderna Inc (NASDAQ: MRNA) has actually lost the quote to revoke a crucial patent related to the advancement of numerous of its next-generation vaccines, including one indicated for coronavirus, to Arbutus Biopharma … [+1967 chars]